12489 Berlin, de
+49 (30) 6706919-129
Capsulution and Schering extend cooperation in research and development
Berlin based companies sign agreement to develop new contrast agents and imaging methods in the field of magnetic resonance technology.
Substantial advances in sensitive imaging methods and special directed contrast agents are indispensable for an early diagnosis and individual therapy of these types of cancer. Capsulutions specially tuned nanocapsules can be a great help in this field. Dr. Andreas Voigt, CSO of Capsulution mentioned: “The effects of cancer disease can be reduced, if the personal risk of developing cancer can be determined at an early state via our LBL-Technologie®.” In addition to radio pharmaceutics, it is possible to use special nanotechnology concepts based on the colloid and interface research; for example magnetized nanocapsules which are linked to targeted ligands.
The project called “Eisenherz” is supported by the German Federal Ministry of Education and Research (BMBF) within the framework of the leading innovation program “Nano-for-Life”. Other partners, like Philips Medizin Systeme GmbH, Siemens AG, Max-Planck Institute (MPI) of Colloids and Interfaces or the German Cancer Research Center are also involved in the project.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to email@example.com.